21 October 2020 · Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Whilst valproate (valproic acid/sodium valproate) is…
29 September 2020 · This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. The monitoring parameters cited…
28 September 2020 · Consensus views of the Pharmaceutical Market Support Group and the UK Clinical Pharmacists Association: Neurosciences Group on the safety and appropriateness of switching between brand…
21 September 2020 · Choice will depend on clinical condition, and should primarily be based on suitability for the patient, rather than safety during breastfeeding. Whilst sodium valproate is…
17 July 2020 · For a small number of medicines, there are differences in equivalent doses of oral formulations of the same medicine. This Q&A considers which medicines may…
22 May 2020 · This Medicines Q&A outlines the causes and symptoms of serotonin syndrome and provides examples of medicines with the potential to cause serotonin syndrome.
2 March 2020 · This Medicines Q&A addresses why there is a limit on the dose and duration of use for carbamazepine suppositories. Summary The maximum recommended daily dose…
16 May 2019 · This updated Medicines Q&A provides advice on a suitable oral contraceptive that can be used in a woman using an enzyme-inducing anti-epileptic or anti-tubercle drug.…
24 January 2019 · The 200 and 400mg immediate release (IR) and 200 and 400 mg prolonged release (PR) tablets (the 100mg IR tablets are no longer marketed) are…
18 October 2018 · Obesity results in physiological changes that can affect the volume of distribution and the clearance of drugs. The extent of these changes is variable and…